Showing 25 of 409 grants in "Health"
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
Deadline: January 29, 2027
Opportunity Number: RFA-AI-28-012
Agency: National Institutes of Health
Open Date: October 20, 2026
Close Date: January 29, 2027
Status: Posted
CFDA Numbers: 93.310, 93.855
National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Deadline: November 1, 2027
Opportunity Number: RFA-DC-28-001
Agency: National Institutes of Health
Open Date: October 20, 2026
Close Date: November 1, 2027
Status: Posted
CFDA Numbers: 93.173
Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Deadline: March 5, 2027
Opportunity Number: RFA-DC-28-002
Agency: National Institutes of Health
Open Date: October 20, 2026
Close Date: March 5, 2027
Status: Posted
CFDA Numbers: 93.173
Immune Tolerance Network (UM1 Clinical Trial Required)
Deadline: January 29, 2027
Opportunity Number: RFA-AI-28-005
Agency: National Institutes of Health
Open Date: October 20, 2026
Close Date: January 29, 2027
Status: Posted
CFDA Numbers: 93.855
Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)
Deadline: July 16, 2029
Opportunity Number: PAR-28-093
Agency: National Institutes of Health
Open Date: October 19, 2026
Close Date: July 16, 2029
Status: Posted
CFDA Numbers: 93.681, 93.279, 93.310
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)
Deadline: May 25, 2029
Opportunity Number: PAR-28-090
Agency: National Institutes of Health
Open Date: October 16, 2026
Close Date: May 25, 2029
Status: Posted
CFDA Numbers: 93.847, 93.242, 93.396, 93.838, 93.866, 93.310, 93.837, 93.989, 93.307, 93.393, 93.840, 93.361, 93.121, 93.394, 93.839, 93.855, 93.279, 93.865, 93.233, 93.395
NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
Deadline: February 11, 2027
Opportunity Number: RFA-LM-28-001
Agency: National Institutes of Health
Open Date: October 16, 2026
Close Date: February 11, 2027
Status: Posted
CFDA Numbers: 93.242, 93.121, 93.398, 93.867, 93.279, 93.310, 93.855, 93.853, 93.173, 93.879
Specialized Alcohol Research Centers (P50 Clinical trial Optional)
Deadline: January 27, 2027
Opportunity Number: RFA-AA-28-001
Agency: National Institutes of Health
Open Date: October 15, 2026
Close Date: January 27, 2027
Status: Posted
CFDA Numbers: 93.273
Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
Deadline: February 11, 2027
Opportunity Number: RFA-CA-28-004
Agency: National Institutes of Health
Open Date: October 15, 2026
Close Date: February 11, 2027
Status: Posted
CFDA Numbers: 93.394
Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
Deadline: November 17, 2026
Opportunity Number: RFA-DK-27-122
Agency: National Institutes of Health
Open Date: October 15, 2026
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.847
Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)
Deadline: November 16, 2029
Opportunity Number: PAR-28-091
Agency: National Institutes of Health
Open Date: October 15, 2026
Close Date: November 16, 2029
Status: Posted
CFDA Numbers: 93.213, 93.473
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
Deadline: October 11, 2029
Opportunity Number: PAR-28-014
Agency: National Institutes of Health
Open Date: October 14, 2026
Close Date: October 11, 2029
Status: Posted
CFDA Numbers: 93.113, 93.393
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
Deadline: September 25, 2029
Opportunity Number: PAR-28-022
Agency: National Institutes of Health
Open Date: October 14, 2026
Close Date: September 25, 2029
Status: Posted
CFDA Numbers: 93.121, 93.395
NIH Research Program Projects (Parent P01 Clinical Trial Optional)
Deadline: May 25, 2029
Opportunity Number: PA-27-061
Agency: National Institutes of Health
Open Date: October 14, 2026
Close Date: May 25, 2029
Status: Posted
CFDA Numbers: 93.866, 93.279, 93.837, 93.839, 93.393, 93.838, 93.313, 93.395, 93.855, 93.394, 93.113, 93.233, 93.396, 93.840, 93.879, 93.307, 93.172, 93.273, 93.399
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional)
Deadline: November 5, 2029
Opportunity Number: PAR-27-090
Agency: National Institutes of Health
Open Date: October 14, 2026
Close Date: November 5, 2029
Status: Posted
CFDA Numbers: 93.361, 93.242, 93.865, 93.393, 93.853, 93.866, 93.307
Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)
Deadline: September 26, 2029
Opportunity Number: PAR-27-003
Agency: National Institutes of Health
Open Date: October 14, 2026
Close Date: September 26, 2029
Status: Posted
CFDA Numbers: 93.173, 93.866, 93.879, 93.473, 93.867, 93.279, 93.853, 93.846, 93.121, 93.855, 93.273, 93.172, 93.859
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
Deadline: February 11, 2027
Opportunity Number: RFA-AI-28-024
Agency: National Institutes of Health
Open Date: October 13, 2026
Close Date: February 11, 2027
Status: Posted
CFDA Numbers: 93.855
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
Deadline: February 9, 2027
Opportunity Number: RFA-CA-28-013
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: February 9, 2027
Status: Posted
CFDA Numbers: 93.399, 93.393, 93.396
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)
Deadline: November 23, 2026
Opportunity Number: RFA-RM-27-007
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: November 23, 2026
Status: Posted
CFDA Numbers: 93.310
NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed)
Deadline: March 1, 2029
Opportunity Number: RFA-AR-28-001
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: March 1, 2029
Status: Posted
CFDA Numbers: 93.313, 93.846
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
Deadline: November 23, 2026
Opportunity Number: RFA-RM-27-016
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: November 23, 2026
Status: Posted
CFDA Numbers: 93.310
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed)
Deadline: November 23, 2026
Opportunity Number: RFA-RM-27-025
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: November 23, 2026
Status: Posted
CFDA Numbers: 93.310
Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)
Deadline: October 13, 2028
Opportunity Number: RFA-HL-27-010
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: October 13, 2028
Status: Posted
CFDA Numbers: 93.840, 93.398, 93.839, 93.855, 93.837, 93.233, 93.838
Neural Ensembles & Used Substances (NExUS) Collaboratory: Building a Multimodal Inventory of Cell Ensembles Encoding the Effects of Addictive Substances (U01 Clinical Trial Not Allowed)
Deadline: February 8, 2027
Opportunity Number: RFA-DA-28-013
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: February 8, 2027
Status: Posted
CFDA Numbers: 93.279
Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)
Deadline: December 14, 2026
Opportunity Number: RFA-HG-27-010
Agency: National Institutes of Health
Open Date: October 9, 2026
Close Date: December 14, 2026
Status: Posted
CFDA Numbers: 93.172